MZB1 | Marginal zone B and B1 cell-specific protein | Predicted secreted proteins
| | | | | Mixed |
NADK2 | NAD kinase 2, mitochondrial | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
NDUFAF2 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 2 | Disease related genes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
NDUFS4 | NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) | Disease related genes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
NDUFS6 | NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) | Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
NHP2 | NHP2 ribonucleoprotein | Disease related genes Predicted intracellular proteins Ribosomal proteins
| | | | | Expressed in all |
NNT | Nicotinamide nucleotide transhydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
NPM1 | Nucleophosmin (nucleolar phosphoprotein B23, numatrin) | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NSUN2 | NOP2/Sun RNA methyltransferase family, member 2 | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
NUDT12 | Nudix (nucleoside diphosphate linked moiety X)-type motif 12 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
OCLN | Occludin | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
P4HA2 | Prolyl 4-hydroxylase, alpha polypeptide II | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
PAM | Peptidylglycine alpha-amidating monooxygenase | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
PAPD7 | PAP associated domain containing 7 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
PDE8B | Phosphodiesterase 8B | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
PDGFRB | Platelet-derived growth factor receptor, beta polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
PHAX | Phosphorylated adaptor for RNA export | Predicted intracellular proteins Transporters
| | | | | Expressed in all |
PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PJA2 | Praja ring finger 2, E3 ubiquitin protein ligase | Predicted intracellular proteins
| | | | | Expressed in all |
POLR3G | Polymerase (RNA) III (DNA directed) polypeptide G (32kD) | Predicted intracellular proteins RNA polymerase related proteins
| | | | | Mixed |
PPAP2A | Phosphatidic acid phosphatase type 2A | Enzymes Predicted membrane proteins
| | | | | Mixed |
PPP2CA | Protein phosphatase 2, catalytic subunit, alpha isozyme | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
PPWD1 | Peptidylprolyl isomerase domain and WD repeat containing 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
PRKAA1 | Protein kinase, AMP-activated, alpha 1 catalytic subunit | Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PROB1 | Proline-rich basic protein 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PTTG1 | Pituitary tumor-transforming 1 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
RAB3C | RAB3C, member RAS oncogene family | Predicted intracellular proteins
| | | | | Group enriched |
RAD17 | RAD17 homolog (S. pombe) | Predicted intracellular proteins
| | | | | Expressed in all |
RAD50 | RAD50 homolog (S. cerevisiae) | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
RAI14 | Retinoic acid induced 14 | Predicted intracellular proteins
| | | | | Mixed |
RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
RBM22 | RNA binding motif protein 22 | Predicted intracellular proteins
| | | | | Expressed in all |
ROPN1L | Rhophilin associated tail protein 1-like | Predicted intracellular proteins
| | | | | Tissue enriched |
SAR1B | Secretion associated, Ras related GTPase 1B | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
SDHA | Succinate dehydrogenase complex, subunit A, flavoprotein (Fp) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
SERINC5 | Serine incorporator 5 | Predicted membrane proteins
| | | | | Expressed in all |
SIL1 | SIL1 nucleotide exchange factor | Disease related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
SKIV2L2 | Superkiller viralicidic activity 2-like 2 (S. cerevisiae) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
SKP2 | S-phase kinase-associated protein 2, E3 ubiquitin protein ligase | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
SLC1A3 | Solute carrier family 1 (glial high affinity glutamate transporter), member 3 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC23A1 | Solute carrier family 23 (ascorbic acid transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC26A2 | Solute carrier family 26 (anion exchanger), member 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC36A2 | Solute carrier family 36 (proton/amino acid symporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC6A18 | Solute carrier family 6 (neutral amino acid transporter), member 18 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC6A19 | Solute carrier family 6 (neutral amino acid transporter), member 19 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC9A3 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLCO6A1 | Solute carrier organic anion transporter family, member 6A1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SMN2 | Survival of motor neuron 2, centromeric | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |